查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106660

連續性腎臟替代療法（CRRT）設備：市場洞察、競爭格局和市場預測 - 2034 年

Continuous Renal Replacement Therapy (CRRT) Machines - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 預計到 2025 年，連續性腎臟替代療法 (CRRT) 設備市場規模將達到 12.5 億美元，到 2034 年將達到 25.2 億美元。這一成長的促進因素包括：全球重症患者急性腎損傷 (AKI) 和膿毒症負擔的加重、加護病房(ICU) 基礎設施的擴建，以及自動化和人工智慧驅動的 CRRT 平台技術的不斷進步。
  • 全球 CRRT 設備市場預計在 2026 年至 2034 年的預測期內將以 8.20% 的複合年成長率成長。
  • 按產品類型分類，預計到 2025 年，設備細分市場將佔 54% 的市場佔有率，從而推動 CRRT 設備市場的發展。
  • 依治療方式分類，預計到 2025 年，連續性靜脈-靜脈血液透析濾過 (CVVHDF) 將在 CRRT 設備市場中佔據主導地位，佔 38%。
  • 按患者群體分類，預計到 2025 年，成人群體將引領 CRRT 設備市場，佔市場佔有率的 78%。
  • 以最終用戶分類，預計到 2025 年，醫院領域將引領 CRRT 設備市場，佔據 65% 的市場佔有率。
  • 到 2025 年，北美將佔全球 CRRT 設備市場收入的 40%，在全球區域市場佔有率中佔最高比例。

與傳統的間歇性血液透析不同，連續性腎臟替代療法（CRRT）是一種專門用於重症監護的醫療設備，可為血流動力學不穩定的重症患者（例如急性腎損傷或多重器官衰竭患者）提供漸進式、持續性的血液淨化。 CRRT 設備透過體外循環迴路和血液濾器循環血液，在 24 小時循環中逐步清除溶質、過量液體和電解質，同時最大限度地減少血流動力學的快速變化。 CRRT 需要使用濾網、導管、透析液和置換液等專用耗材。由於入住加護病房的重症患者通常無法耐受標準透析帶來的體液容量和溶質的快速波動，CRRT 已成為重症監護環境下腎功能支援的標準治療方法。市場按產品類型（設備和耗材）、治療類型（慢速連續超過濾(SCUF)、連續靜脈-靜脈血液濾過 (CVVH)、連續靜脈-靜脈血液透析 (CVVHD)、連續靜脈-靜脈血液透析濾過 (CVVHDF)）、患者類型（成人和兒童）以及終端用戶類型（醫院、透析中心及其他機構）進行細分。受全球急性腎損傷和膿毒症發病率上升、重症監護病房容量擴大、老年和重症患者數量增加以及自動化、人工智慧驅動和攜帶式CRRT 平台技術的不斷創新等因素的推動，CRRT 設備已成為全球重症監護中維持腎功能的重要基礎設施。

連續性腎臟替代療法（CRRT）設備市場的主要市場促進因素

  • 全球急性腎損傷 (AKI) 發病率不斷上升，推動了市場需求。國際腎臟病學會 (ISN) 估計，全球每年約有 1,330 萬例 AKI 病例，其中約 1,130 萬例集中在新興經濟體。
  • 據全球膿毒症聯盟稱，膿毒症在全球範圍內高發，估計每年影響 4700 萬至 5000 萬人，這推動了對持續腎臟替代療法的需求，以控制重症患者的體液平衡並清除炎症毒素。
  • 隨著 ICU 容量的擴大和重症患者住院率的上升，需要持續、血液動力學可耐受的腎臟替代治療的潛在患者群體正在擴大。
  • 持續的產品開發和下一代平台的引入，包括自動化管理、整合數位連接和簡化的電路設置，正在提高可用性並加快整個 ICU 的設備更新周期。
  • 由於全球人口老化以及糖尿病、高血壓和心血管疾病等合併症的盛行率不斷上升，急性腎損傷和慢性腎臟病（需要在急性期進行腎臟支持）的發生率正在增加。
  • AI 整合、遠端監控的 CRRT 平台的日益普及提高了治療準確性，減輕了臨床醫生的負擔，支持了整個重症監護領域的分散式和可攜式交付模式，並擴大了新興經濟體的醫療保健基礎設施。
  • 急性腎損傷 (AKI) 和敗血症的日益嚴重，加上重症監護室 (ICU) 的擴容和平台的持續創新，預計將推動到 2034 年實現穩定的中等個位數成長。

推動連續性腎臟替代療法（CRRT）設備市場成長的因素

市場促進因素

全球急性腎損傷（AKI）負擔日益加重

CRRT設備市場最根本的驅動力是重症患者急性腎損傷（AKI）在全球持續高發生率。根據國際腎臟病學會（ISN）估計，全球每年約有1,330萬例急性腎損傷（AKI）病例，其中大部分集中在新興經濟體，估計每年約有1,130萬例。 AKI通常與敗血症、重大手術、創傷和多重器官衰竭有關，而血流動力學不穩定的患者往往無法耐受傳統間歇性血液透析帶來的快速體液和溶質波動。 CRRT能夠逐步、持續地清除體液和溶質，是這些情況下首選的腎臟替代療法。此外，隨著重症監護能力的提升，AKI的發生率持續上升，預計到2034年，對CRRT設備及相關耗材的需求也將隨之成長。

全球膿毒症高發生

敗血症是重症加護病房（ICU）收治的主要原因之一，也是連續性腎臟替代療法（CRRT）的主要適應症。根據全球膿毒症聯盟（Global Sepsis Alliance）最新發布的估計數據，全球每年約有4700萬至5000萬人患有膿毒症，而CRRT被廣泛用於治療與嚴重膿毒症和敗血性休克相關的體液超負荷、電解質紊亂和炎症毒素負荷。 2012年，全球膿毒症聯盟提議設立“世界膿毒症日”，進一步提高了臨床醫生和公眾對膿毒症管理的認知，包括CRRT的作用。鑑於全球膿毒症發病率持續居高不下，且CRRT擴大被納入ICU血流動力學穩定方案，預計在預測期內，對相關設備和耗材的強勁需求將持續存在。

市場限制因素

儘管CRRT設備市場穩定成長，但仍面臨諸多限制因素。由於CRRT本身可能導致血流動力學不穩定、體液失衡和電解質水平改變，因此需要經驗豐富的護理人員和醫生進行細緻的臨床管理和監督，這限制了其在資源匱乏地區的普及。除了CRRT設備高昂的初始投資成本外，諸如過濾器、導管、透析液、置換液和抗凝血劑等專用耗材的持續成本也對新興經濟體的小規模醫院和醫療系統構成經濟障礙。此外，重症監護護理師和接受過持續腎臟支持培訓的臨床醫生短缺進一步限制了CRRT的普及，而主要市場嚴格的監管合規要求則延長了產品開發和核准週期。 CRRT手術的保險報銷政策也因地區而異，對少數成熟設備和耗材供應商的依賴加劇了供應風險。儘管存在諸如急性腎損傷 (AKI) 和敗血症負擔加重、ICU 擴建以及平台創新等潛在促進因素，但臨床、資本、人力和保險報銷方面的障礙加在一起，正在減緩成長速度。

目錄

第1章：連續性腎臟替代療法（CRRT）設備市場：簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：連續性腎臟替代療法（CRRT）設備市場：執行摘要

  • 市場概覽

第3章 連續性腎臟替代療法（CRRT）設備市場：關鍵因素分析

  • 連續性腎臟替代療法（CRRT）設備市場：市場促進因素
    • 全球範圍內急性腎損傷負擔日益加重
    • 全球膿毒症高發生
    • 重症加護病房基礎設施擴建住院病人人數增加
    • 持續的產品開發與平台創新
  • 連續性腎臟替代療法（CRRT）設備市場：限制因素與挑戰
    • 存在血流動力學不穩定和電解質失衡的風險。
    • 高昂的資本投資成本和消耗品成本
    • 法規、人員和還款機制的複雜性。
  • 連續性腎臟替代療法（CRRT）設備市場：市場機會
    • 人工智慧驅動的管理和自動化擴展
    • 新興市場和可攜式平台的擴張

第4章：人工智慧、地緣政治、貿易與經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力分析

第7章：連續性腎臟替代療法（CRRT）設備市場：評估

  • 依產品類型
    • 裝置
    • 消耗品
  • 按模式
    • 慢速連續超過濾（SCUF）
    • 連續性靜脈血液濾過（CVVH）
    • 連續性靜脈血液透析（CVVHD）
    • 連續性靜脈血液透析濾過（CVVHDF）
  • 患者
    • 成人
    • 兒童
  • 最終用戶
    • 醫院
    • 透析中心
    • 其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章 連續性腎臟替代療法（CRRT）設備市場：競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：連續性腎臟替代療法（CRRT）設備市場：新創企業資金籌措與投資趨勢

第10章：連續性腎臟替代療法（CRRT）設備市場：公司概況與產品概況

  • Baxter
  • Fresenius Medical Care AG
  • NIKKISO CO., LTD
  • B.Braun Melsungen AG
  • Asahi Kasei Corporation
  • Infomed SA
  • Medtronic
  • NxStage Medical, Inc.
  • Medica SpA
  • SWS Hemodialysis Care Co.

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0004

Continuous Renal Replacement Therapy (CRRT) Machines Market Summary

Overview:

  • The Continuous Renal Replacement Therapy (CRRT) Machines market is estimated at USD 1.25 billion in 2025 and is projected to reach USD 2.52 billion by 2034. Growth is anchored in the rising global burden of acute kidney injury (AKI) and sepsis in critically ill patients, expanding intensive care unit (ICU) infrastructure, and continued technological advancement in automated, AI-enabled CRRT platforms.
  • The global CRRT Machines market is growing at a CAGR of 8.20% during the forecast period from 2026 to 2034.
  • By product type, the machines segment dominated the CRRT Machines market with a 54% share in 2025.
  • By modality, the continuous venovenous hemodiafiltration (CVVHDF) segment dominated the CRRT Machines market with a 38% share in 2025.
  • By patient, the adult segment dominated the CRRT Machines market with a 78% share in 2025.
  • By end-user, the hospitals segment dominated the CRRT Machines market with a 65% share in 2025.
  • North America dominated the global CRRT Machines market revenue with a 40% share in 2025, representing the highest regional market share globally.

A Continuous Renal Replacement Therapy (CRRT) machine is a specialized critical-care device that provides slow, continuous blood purification for hemodynamically unstable, critically ill patients with acute kidney injury or multi-organ failure, in contrast to conventional intermittent hemodialysis. CRRT machines circulate blood through an extracorporeal circuit and hemofilter, gradually removing solutes, excess fluid, and electrolytes over 24-hour cycles while minimizing rapid hemodynamic shifts, and are supported by dedicated consumables including filters, catheters, dialysates, and replacement solutions. Because critically ill patients in the ICU often cannot tolerate the rapid fluid and solute changes associated with standard dialysis, CRRT has become the standard of care for renal support in intensive care settings. The market is organized by product type across machines and consumables; by modality across slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF); by patient across adult and pediatric populations; and by end-user across hospitals, dialysis centres, and others. Driven by the rising global incidence of acute kidney injury and sepsis, expanding ICU capacity, growing geriatric and critically ill patient populations, and continued innovation in automated, AI-enabled, and portable CRRT platforms, CRRT machines have become essential infrastructure underpinning critical-care renal support worldwide.

Continuous Renal Replacement Therapy (CRRT) Machines Market Key Growth Drivers

  • The rising global incidence of acute kidney injury is driving demand, with the International Society of Nephrology estimating approximately 13.3 million cases of AKI annually worldwide, with a disproportionate burden of roughly 11.3 million cases in emerging economies.
  • The high global prevalence of sepsis, affecting an estimated 47 to 50 million individuals each year according to the Global Sepsis Alliance, is expanding demand for continuous renal support to manage fluid balance and remove inflammatory toxins in critically ill patients.
  • Expanding ICU capacity and rising hospital admission rates for critically ill patients are increasing the addressable base of patients requiring continuous, hemodynamically tolerable renal replacement therapy.
  • Continued product development and next-generation platform launches, including automated dosing, integrated digital connectivity, and simplified circuit set-up, are improving usability and driving equipment upgrade cycles across ICUs.
  • The aging global population and rising prevalence of comorbidities such as diabetes, hypertension, and cardiovascular disease are increasing the incidence of both acute kidney injury and chronic kidney disease requiring renal support in acute settings.
  • Growing adoption of AI-integrated and remotely monitored CRRT platforms is improving treatment precision, reducing clinician burden, and supporting decentralized and portable delivery models across critical care and expanding healthcare infrastructure in emerging economies.
  • The convergence of rising AKI and sepsis burden, ICU expansion, and continuous platform innovation is expected to sustain steady, high-single-digit growth in the market through 2034.

Key Companies in Continuous Renal Replacement Therapy (CRRT) Machines Market

The competitive landscape is led by the following active device manufacturers:

  • Baxter
  • Fresenius Medical Care AG
  • NIKKISO CO., LTD
  • B.Braun Melsungen AG
  • Asahi Kasei Corporation
  • Infomed SA
  • Medtronic
  • NxStage Medical, Inc.
  • Medica S.p.A.
  • SWS Hemodialysis Care Co.

Factors Contributing to the Growth of the Continuous Renal Replacement Therapy (CRRT) Machines Market

Market Drivers

Rising Global Burden of Acute Kidney Injury

The most fundamental driver of the CRRT Machines market is the persistently high global incidence of acute kidney injury among critically ill patients. The International Society of Nephrology estimates approximately 13.3 million cases of AKI occur annually worldwide, with an outsized share concentrated in emerging economies where an estimated 11.3 million cases arise each year. AKI frequently accompanies sepsis, major surgery, trauma, and multi-organ failure, and hemodynamically unstable patients are often unable to tolerate the rapid fluid and solute shifts associated with conventional intermittent hemodialysis. CRRT's gradual, continuous approach to fluid and solute removal makes it the preferred renal support modality in these settings, and as AKI incidence continues to rise alongside expanding critical-care capacity, demand for CRRT machines and their associated consumables grows correspondingly through 2034.

High Global Prevalence of Sepsis

Sepsis is a leading driver of ICU admissions and a major indication for continuous renal support. The Global Sepsis Alliance's recently updated estimates indicate that sepsis affects between 47 and 50 million individuals globally each year, and CRRT is widely used to manage the fluid overload, electrolyte disturbance, and inflammatory toxin burden associated with severe sepsis and septic shock. Global observance of World Sepsis Day, initiated by the Global Sepsis Alliance in 2012, has further raised clinical and public awareness of sepsis management, including the role of continuous renal replacement therapies. As sepsis incidence remains elevated worldwide and ICU protocols increasingly incorporate CRRT for hemodynamic stabilization, this driver is expected to sustain robust equipment and consumable demand across the forecast period.

Market Restraints

Despite steady momentum, the CRRT Machines market faces material constraints. CRRT can itself contribute to hemodynamic instability, fluid imbalance, and alteration of blood electrolyte levels, requiring careful clinical management and skilled nursing and physician oversight that can limit adoption in resource-constrained settings. The high capital cost of CRRT machines and the recurring cost of specialized consumables, including filters, catheters, dialysates, and replacement and anticoagulation solutions, create affordability barriers for smaller hospitals and healthcare systems in emerging economies. A shortage of critical-care nursing staff and clinicians trained in continuous renal support further constrains scale-up, while stringent regulatory compliance requirements across major markets lengthen product development and approval timelines. Reimbursement policies for CRRT procedures also vary considerably across geographies, and dependence on a limited number of established equipment and consumable suppliers concentrates supply risk. Together, these clinical, capital, workforce, and reimbursement barriers temper the pace of growth, even as the underlying drivers of rising AKI and sepsis burden, ICU expansion, and platform innovation remain firmly intact.

Continuous Renal Replacement Therapy (CRRT) Machines Market Segment Analysis

The Continuous Renal Replacement Therapy (CRRT) Machines by Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Machines.

Dominant: Machine ~ 54%

The machines segment accounted for 54% of the CRRT Machines market in 2025. Machines lead the product-type segmentation because CRRT systems represent the primary capital equipment investment for hospitals building or expanding critical-care renal support capacity, and each new or replacement ICU bed dedicated to continuous renal therapy requires a control unit and associated hardware. Manufacturers continue to compete on automation, integrated digital connectivity, and simplified circuit set-up, which drives replacement and upgrade cycles among hospitals seeking to standardize on next-generation platforms. While consumables, including filters, catheters, dialysates, and replacement solutions, generate the more frequent, recurring revenue associated with each treatment cycle and are growing quickly as CRRT procedure volumes rise, the substantial upfront cost and multi-year replacement cycle of machines secures the segment's leadership by revenue share across the forecast period.

By Modality

Dominant Subsegment: Continuous Venovenous Hemodiafiltration (CVVHDF).

Dominant: CVVHDF ~ 38%

The continuous venovenous hemodiafiltration (CVVHDF) segment accounted for 38% of the CRRT Machines market in 2025. CVVHDF is the leading modality because it combines diffusion and convection, enabling comprehensive clearance of both small and middle-molecular-weight solutes alongside precise fluid management, making it well suited to critically ill patients with complex metabolic imbalances, sepsis, and multi-organ dysfunction. Its operational flexibility and ability to be tailored to individual patient needs have driven growing clinician preference over single-mechanism modalities. Continuous venovenous hemofiltration (CVVH) remains widely used and continues to hold a meaningful revenue share given its established convective clearance profile, while continuous venovenous hemodialysis (CVVHD) is valued for its effectiveness in managing fluid overload through diffusive clearance. Slow continuous ultrafiltration (SCUF), used primarily for isolated fluid removal, holds the smallest share given its narrower clinical indication. Nonetheless, the comprehensive clearance profile and rising clinical preference for CVVHDF secure its leadership across the forecast period.

Continuous Renal Replacement Therapy (CRRT) Machines Market Region Analysis

Dominant Region: North America

Dominant: North America ~ 40% (Largest)

North America accounted for 40% of the global CRRT Machines market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high prevalence of end-stage and acute renal conditions, a mature and well-established critical-care infrastructure, clear FDA regulatory pathways, and the concentrated presence of leading CRRT manufacturers. North America hosts an extensive network of hospital ICUs equipped for continuous renal support, and favorable reimbursement frameworks for acute-care dialysis procedures encourage hospitals to maintain adequate CRRT equipment inventories. Continued investment in next-generation platforms featuring AI-powered dosing algorithms and integrated electronic health record connectivity, combined with strong clinical awareness of CRRT's hemodynamic advantages over intermittent dialysis, anchors the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the CRRT Machines market. The region's elevated CAGR is driven by the rapidly aging population, rising incidence of kidney disorders, and expanding critical-care and hospital infrastructure across China, Japan, India, South Korea, and Australia. China is expanding hospital ICU capacity and domestic device manufacturing, Japan continues to refine advanced renal-support protocols within its established dialysis ecosystem, and India is benefiting from rising healthcare investment and growing awareness of CRRT's advantages over conventional dialysis in critical-care settings. Government healthcare investment, expanding critically ill patient populations, and growing local manufacturing of CRRT machines and consumables are accelerating adoption across the region, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 40% of the global CRRT Machines market revenue in 2025. The United States dominates on the strength of its critical-care infrastructure, established reimbursement pathways for acute-care renal support, and the concentrated presence of leading manufacturers, while continued investment in AI-enabled and digitally connected CRRT platforms reinforces its leadership.

Europe

Europe is a large and technologically advanced regional market, supported by established regulatory frameworks, a strong base of critical-care research, and a concentrated presence of leading manufacturers headquartered in Germany and Switzerland. Continued platform innovation across Germany, France, the United Kingdom, Italy, and Spain reinforces the region's role in both diagnostic and therapeutic critical-care renal support.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by the rapidly aging population, rising kidney disorder incidence, and expanding hospital and ICU infrastructure across China, Japan, India, South Korea, and Australia. Growing local manufacturing capacity and healthcare investment are accelerating regional adoption of CRRT machines and consumables.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and critical-care infrastructure, rising awareness of continuous renal support, and gradual alignment of regulatory frameworks with global standards are broadening access, while international partnerships support the build-out of regional critical-care capacity.

Continuous Renal Replacement Therapy (CRRT) Machines Market Competitive Landscape

The CRRT Machines market is classified as Moderately Fragmented. A group of large, diversified medical device manufacturers with established critical-care portfolios, including Baxter, Fresenius Medical Care AG, B.Braun Melsungen AG, and Medtronic, anchor the top tier through broad platform availability and global distribution networks, while specialized providers such as NIKKISO CO., LTD, Asahi Kasei Corporation, Infomed SA, NxStage Medical, Inc., Medica S.p.A., and SWS Hemodialysis Care Co. compete through regional manufacturing strength, focused product portfolios, and targeted geographic reach.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Moderately fragmented, with diversified global leaders competing alongside specialized regional device manufacturers.
  • Leading players: Baxter, Fresenius Medical Care AG, B.Braun Melsungen AG, and Medtronic anchor the top tier through broad critical-care portfolios and global reach.
  • Geographic reach: Leading manufacturers operate global distribution and service networks essential for supporting ICU customers across major and emerging markets.
  • Product portfolio strength: Top players offer integrated CRRT platforms spanning control units, disposable circuit sets, filters, and digital connectivity solutions.
  • Technology and automation: Automated dosing, simplified pre-connected circuits, and integrated digital health connectivity are decisive competitive differentiators.
  • Regional manufacturing strength: Specialized players such as NIKKISO, Asahi Kasei, and SWS Hemodialysis Care leverage regional manufacturing bases to serve Asia-Pacific hospital demand.
  • Manufacturing capabilities: Precision fluid-management engineering, hemofilter membrane technology, and regulatory-compliant manufacturing are key competitive moats.
  • Innovation focus: AI-enabled dosing algorithms, portable and decentralized CRRT platforms, and enhanced digital connectivity for ICU quality-improvement programs.

Continuous Renal Replacement Therapy (CRRT) Machines Market Recent Developmental Activities

In 2025-2026, Baxter continued the global rollout of its PrisMax continuous renal replacement therapy platform, including its TrueVue digital health connectivity solutions designed to support ICU quality-improvement programs. Strategic significance: Reinforces Baxter's leadership in automated, digitally connected CRRT platforms across hospital ICUs.

Continuous Renal Replacement Therapy (CRRT) Machines Market Segmentation

Continuous Renal Replacement Therapy (CRRT) Machines Market by Product Type

  • Machines
  • Consumables

Continuous Renal Replacement Therapy (CRRT) Machines Market by Modality

  • Slow Continuous Ultrafiltration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Continuous Renal Replacement Therapy (CRRT) Machines Market by Patient

  • Adult
  • Pediatric

Continuous Renal Replacement Therapy (CRRT) Machines Market by End User

  • Hospitals
  • Dialysis Centers
  • Others

Continuous Renal Replacement Therapy (CRRT) Machines Market by Geography

  • North America Continuous Renal Replacement Therapy (CRRT) Machines Market
  • United States Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Canada Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Mexico Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Europe Continuous Renal Replacement Therapy (CRRT) Machines Market
  • Germany Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • United Kingdom Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • France Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Italy Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Spain Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Rest of Europe Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market
  • China Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Japan Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • India Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Australia Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • South Korea Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Continuous Renal Replacement Therapy (CRRT) Machines Market
  • Middle East Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • Africa Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
  • South America Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)

Key Takeaways from the Continuous Renal Replacement Therapy (CRRT) Machines Market Report Study

  • Market size analysis for the current Continuous Renal Replacement Therapy (CRRT) Machines market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global Continuous Renal Replacement Therapy (CRRT) Machines market.
  • Various opportunities available for competitors in the Continuous Renal Replacement Therapy (CRRT) Machines market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current Continuous Renal Replacement Therapy (CRRT) Machines market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for Continuous Renal Replacement Therapy (CRRT) Machines market growth in the future?

Target audience who can benefit from this Continuous Renal Replacement Therapy (CRRT) Machines market report study

  • Continuous Renal Replacement Therapy (CRRT) Machines product providers
  • Research organizations and consulting companies
  • Continuous Renal Replacement Therapy (CRRT) Machines-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Continuous Renal Replacement Therapy (CRRT) Machines
  • Various end-users who want to know more about the Continuous Renal Replacement Therapy (CRRT) Machines market and the latest technological developments in the Continuous Renal Replacement Therapy (CRRT) Machines market.

Frequently Asked Questions:

Q1. What is the growth rate of the Continuous Renal Replacement Therapy (CRRT) Machines market?

The Continuous Renal Replacement Therapy (CRRT) Machines market is projected to expand at a CAGR of 8.20% during the forecast period from 2026-2034.

Q2. What is the market size of the Continuous Renal Replacement Therapy (CRRT) Machines market?

The Continuous Renal Replacement Therapy (CRRT) Machines market is estimated at USD 1.25 billion in 2025 and is projected to reach USD 2.52 billion by 2034.

Q3. Which region dominates the Continuous Renal Replacement Therapy (CRRT) Machines market?

North America dominated the CRRT Machines market with a 40% share of global revenue in 2025, supported by a mature critical-care infrastructure, established reimbursement pathways, FDA regulatory clarity, and the concentrated presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Continuous Renal Replacement Therapy (CRRT) Machines market?

The principal drivers are the rising global burden of acute kidney injury, with an estimated 13.3 million cases occurring annually worldwide; the high global prevalence of sepsis, affecting an estimated 47 to 50 million individuals each year; expanding ICU infrastructure and rising hospital admissions; continuous product development and platform innovation; and the aging global population's rising comorbidity burden.

Q5. Who are the major players in the Continuous Renal Replacement Therapy (CRRT) Machines market?

The major players include Baxter, Fresenius Medical Care AG, NIKKISO CO., LTD, B.Braun Melsungen AG, Asahi Kasei Corporation, Infomed SA, Medtronic, NxStage Medical, Inc., Medica S.p.A., and SWS Hemodialysis Care Co., among other active providers profiled in the Competitive Landscape section.

Table of Contents

1. Continuous Renal Replacement Therapy (CRRT) Machines Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Continuous Renal Replacement Therapy (CRRT) Machines Market Executive Summary

  • 2.1 Market at a Glance

3. Continuous Renal Replacement Therapy (CRRT) Machines Market Key Factors Analysis

  • 3.1 Continuous Renal Replacement Therapy (CRRT) Machines Market Drivers
    • 3.1.1 Rising Global Burden of Acute Kidney Injury
    • 3.1.2 High Global Prevalence of Sepsis
    • 3.1.3 Expanding ICU Infrastructure and Hospital Admissions
    • 3.1.4 Continuous Product Development and Platform Innovation
  • 3.2 Continuous Renal Replacement Therapy (CRRT) Machines Market Restraints and Challenges
    • 3.2.1 Hemodynamic Instability and Electrolyte Imbalance Risk
    • 3.2.2 High Capital and Consumable Costs
    • 3.2.3 Regulatory, Workforce, and Reimbursement Complexity
  • 3.3 Continuous Renal Replacement Therapy (CRRT) Machines Market Opportunities
    • 3.3.1 AI-Enabled Dosing and Automation Scale-Up
    • 3.3.2 Emerging-Market and Portable Platform Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Continuous Renal Replacement Therapy (CRRT) Machines Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Continuous Renal Replacement Therapy (CRRT) Machines Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Machines
    • 7.1.2 Consumables
  • 7.2 By Modality
    • 7.2.1 Slow Continuous Ultrafiltration (SCUF)
    • 7.2.2 Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3 Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3 By Patient
    • 7.3.1 Adult
    • 7.3.2 Pediatric
  • 7.4 By End-User
    • 7.4.1 Hospitals
    • 7.4.2 Dialysis Centers
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 Germany Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.2.2 United Kingdom Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.2.3 France Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.3.3 India Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
    • 7.5.4 Rest of World
      • 7.5.4.1 Middle East Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Continuous Renal Replacement Therapy (CRRT) Machines Market Size in USD million (2023-2034)

8. Continuous Renal Replacement Therapy (CRRT) Machines Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Continuous Renal Replacement Therapy (CRRT) Machines Market Startup Funding and Investment Trends

10. Continuous Renal Replacement Therapy (CRRT) Machines Market Company and Product Profiles

  • 10.1 Baxter
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Fresenius Medical Care AG
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 NIKKISO CO., LTD
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 B.Braun Melsungen AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Asahi Kasei Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Infomed SA
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 Medtronic
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 NxStage Medical, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Medica S.p.A.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 SWS Hemodialysis Care Co.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global (2023-2034)
  • Table 2: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Product Type(2023-2034)
  • Table 3: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Modality (2023-2034)
  • Table 4: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Patient (2023-2034)
  • Table 5: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by End-Users (2023-2034)
  • Table 6: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Geography (2023-2034)
  • Table 7: Continuous Renal Replacement Therapy (CRRT) Machines Market in North America (2023-2034)
  • Table 8: Continuous Renal Replacement Therapy (CRRT) Machines Market in the United States (2023-2034)
  • Table 9: Continuous Renal Replacement Therapy (CRRT) Machines Market in Canada (2023-2034)
  • Table 10: Continuous Renal Replacement Therapy (CRRT) Machines Market in Mexico (2023-2034)
  • Table 11: Continuous Renal Replacement Therapy (CRRT) Machines Market in Europe (2023-2034)
  • Table 12: Continuous Renal Replacement Therapy (CRRT) Machines Market in Germany (2023-2034)
  • Table 13: Continuous Renal Replacement Therapy (CRRT) Machines Market in United Kingdom (2023-2034)
  • Table 14: Continuous Renal Replacement Therapy (CRRT) Machines Market in France (2023-2034)
  • Table 15: Continuous Renal Replacement Therapy (CRRT) Machines Market in Italy (2023-2034)
  • Table 16: Continuous Renal Replacement Therapy (CRRT) Machines Market in Spain (2023-2034)
  • Table 17: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Rest of Europe (2023-2034)
  • Table 18: Continuous Renal Replacement Therapy (CRRT) Machines Market in Asia-Pacific (2023-2034)
  • Table 19: Continuous Renal Replacement Therapy (CRRT) Machines Market in China (2023-2034)
  • Table 20: Continuous Renal Replacement Therapy (CRRT) Machines Market in Japan (2023-2034)
  • Table 21: Continuous Renal Replacement Therapy (CRRT) Machines Market in India (2023-2034)
  • Table 22: Continuous Renal Replacement Therapy (CRRT) Machines Market in Australia (2023-2034)
  • Table 23: Continuous Renal Replacement Therapy (CRRT) Machines Market in South Korea (2023-2034)
  • Table 24: Continuous Renal Replacement Therapy (CRRT) Machines Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Rest of the World (2023-2034)
  • Table 26: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Middle East (2023-2034)
  • Table 27: Continuous Renal Replacement Therapy (CRRT) Machines Market in Africa (2023-2034)
  • Table 28: Continuous Renal Replacement Therapy (CRRT) Machines Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Continuous Renal Replacement Therapy (CRRT) Machines Market Drivers
  • Figure 2: Continuous Renal Replacement Therapy (CRRT) Machines Market Restraints
  • Figure 3: Continuous Renal Replacement Therapy (CRRT) Machines Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global (2023-2034)
  • Figure 9: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Product Type(2023-2034)
  • Figure 10: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Modality (2023-2034)
  • Figure 11: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Patient (2023-2034)
  • Figure 12: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by End-Users (2023-2034)
  • Figure 13: Continuous Renal Replacement Therapy (CRRT) Machines Market in Global by Geography (2023-2034)
  • Figure 14: Continuous Renal Replacement Therapy (CRRT) Machines Market in North America (2023-2034)
  • Figure 15: Continuous Renal Replacement Therapy (CRRT) Machines Market in the United States (2023-2034)
  • Figure 16: Continuous Renal Replacement Therapy (CRRT) Machines Market in Canada (2023-2034)
  • Figure 17: Continuous Renal Replacement Therapy (CRRT) Machines Market in Mexico (2023-2034)
  • Figure 18: Continuous Renal Replacement Therapy (CRRT) Machines Market in Europe (2023-2034)
  • Figure 19: Continuous Renal Replacement Therapy (CRRT) Machines Market in Germany (2023-2034)
  • Figure 20: Continuous Renal Replacement Therapy (CRRT) Machines Market in United Kingdom (2023-2034)
  • Figure 21: Continuous Renal Replacement Therapy (CRRT) Machines Market in France (2023-2034)
  • Figure 22: Continuous Renal Replacement Therapy (CRRT) Machines Market in Italy (2023-2034)
  • Figure 23: Continuous Renal Replacement Therapy (CRRT) Machines Market in Spain (2023-2034)
  • Figure 24: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Rest of Europe (2023-2034)
  • Figure 25: Continuous Renal Replacement Therapy (CRRT) Machines Market in Asia-Pacific (2023-2034)
  • Figure 26: Continuous Renal Replacement Therapy (CRRT) Machines Market in China (2023-2034)
  • Figure 27: Continuous Renal Replacement Therapy (CRRT) Machines Market in Japan (2023-2034)
  • Figure 28: Continuous Renal Replacement Therapy (CRRT) Machines Market in India (2023-2034)
  • Figure 29: Continuous Renal Replacement Therapy (CRRT) Machines Market in Australia (2023-2034)
  • Figure 30: Continuous Renal Replacement Therapy (CRRT) Machines Market in South Korea (2023-2034)
  • Figure 31: Continuous Renal Replacement Therapy (CRRT) Machines Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Rest of the World (2023-2034)
  • Figure 33: Continuous Renal Replacement Therapy (CRRT) Machines Market in the Middle East (2023-2034)
  • Figure 34: Continuous Renal Replacement Therapy (CRRT) Machines Market in Africa (2023-2034)
  • Figure 35: Continuous Renal Replacement Therapy (CRRT) Machines Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding and Investment Trends